Universite de Strasbourg;Centre National de la Recherche Scientifique
发明人:
Ruat, Martial,Faure, Helene,Roudaut, Hermine,Hoch, Lucile,Schoenfelder, Angele,Taddei, Maurizio,Mann, Andre
申请号：
AU2012311079
公开号：
AU2012311079A1
申请日:
2012.09.21
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The present invention relates to novel compounds having the following formula (I), and the use thereof as a drug, particularly for the treatment of tumors associated with hyperactivation of the hedgehog protein signaling pathway, for the treatment of neurodegenerative diseases, for the treatment of diseases related to cerebral development (holoprosencephaly), for stem cell monitoring, for the treatment of cerebrovascular accidents and cardiovascular accidents, for the treatment of diseases involving oligodendrocytes and diseases involving neurolemmocytes, for application thereof
